This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://www.businesswire.com/news/home/20260429144139/en/Ray-Therapeutics-Granted-Priority-Medicines-PRIME-Designation-from-the-European-Medicines-Agency-for-RTx-015-in-Retinitis-Pigmentosa